Condensed Balance Sheets - USD ($) $ in Thousands	Mar. 31, 2025	Dec. 31, 2024	[1]
Current assets
Cash and cash equivalents	$ 91,936	$ 71,188
Short-term investments	213,709	284,536
Prepaid expenses and other current assets (Note 5)	5,546	6,540
Total current assets	311,191	362,264
Property and equipment, net (Note 4)	5,240	5,525
Operating lease right-of-use assets (Note 15)	26,430	27,243
Restricted cash	1,482	1,482
Other non-current assets	427	435
Total assets	344,770	396,949
Current liabilities
Accounts payable	5,622	5,960
Accrued research and development	14,381	14,363
Accrued liabilities (Note 6)	7,429	12,353
Operating lease liabilities, current (Note 15)	771	542
Total current liabilities	28,203	33,218
Operating lease liabilities, non-current (Note 15)	29,119	29,439
Long-term debt (Note 7)	30,284	30,211
Total liabilities	87,606	92,868
Commitments and Contingencies (Note 14)
Stockholders’ equity
Preferred stock, $0.0001 par value per share; 10,000,000 shares authorized at March 31, 2025 and December 31, 2024, 300,000 shares designated as Series A Junior Participating Preferred Stock at March 31, 2025 and none designated as Series A Junior Participating Preferred Stock at December 31, 2024; and none issued or outstanding at March 31, 2025 and December 31, 2024 (Note 8 and 10)	0	0
Common stock, $0.0001 par value per share; 300,000,000 shares authorized at March 31, 2025 and December 31, 2024; and 61,386,183 and 60,860,838 shares issued and outstanding at March 31, 2025 and December 31, 2024, respectively; (Note 9)	6	6
Additional paid-in capital	1,023,217	1,013,806
Accumulated deficit	(766,218)	(710,052)
Accumulated other comprehensive gain	159	321
Total stockholders’ equity	257,164	304,081
Total liabilities and stockholders’ equity	$ 344,770	$ 396,949

[1] The condensed balance sheet as of December 31, 2024 has been derived from the audited financial statements as of that date.